Literature DB >> 4116300

Circulating C-peptide immunoreactivity. Studies in normals and diabetic patients.

M B Block, M E Mako, D F Steiner, A H Rubenstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4116300     DOI： 10.2337/diab.21.10.1013

Source DB:  PubMed          Journal:  Diabetes        ISSN： 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  34 in total

1.  Serum IRI in insulin-treated diabetics during a 24-hour period.

Authors:  S M Rasmussen; L G Heding; E Parbst; A Volund
Journal:  Diabetologia       Date:  1975-04       Impact factor: 10.122

2.  Human C-peptide in normal and diabetic subjects.

Authors:  L G Heding; S M Rasmussen
Journal:  Diabetologia       Date:  1975-06       Impact factor: 10.122

3.  Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.

Authors:  D L Horwitz; J I Starr; M E Mako; W G Blackard; A H Rubenstein
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

4.  B-cell function and blood glucose control in insulin dependent diabetics within the first month of insulin treatment.

Authors:  O K Faber; C Binder
Journal:  Diabetologia       Date:  1977-05       Impact factor: 10.122

5.  One hundred pancreas transplants at a single institution.

Authors:  D E Sutherland; F C Goetz; J S Najarian
Journal:  Ann Surg       Date:  1984-10       Impact factor: 12.969

Review 6.  The renal metabolism of insulin.

Authors:  R Rabkin; M P Ryan; W C Duckworth
Journal:  Diabetologia       Date:  1984-09       Impact factor: 10.122

7.  Metabolic and endocrine responses to a standard mixed meal. A physiologic study.

Authors:  M Zaccaria; E De Palo; E Zago; N Sicolo; G Erle; G Federspil
Journal:  Acta Diabetol Lat       Date:  1979 Jan-Mar

8.  Circadian variation of serum glucose, C-peptide immunoreactivity and free insulin normal and insulin-treated diabetic pregnant subjects.

Authors:  S B Lewis; J D Wallin; H Kuzuya; W K Murray; D R Coustan; T A Daane; A H Rubenstein
Journal:  Diabetologia       Date:  1976-08       Impact factor: 10.122

9.  Human C-peptide. Part II: Clinical studies.

Authors:  W Beischer; E Heinze; L Keller; S Raptis; W Kerner; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1976-08-01

10.  Human C-peptide immunoreactivity (CPR) in blood and urine - evaluation of a radioimmunoassay method and its clinical applications.

Authors:  T Kuzuya; T Saito; S Yoshida; A Matsuda
Journal:  Diabetologia       Date:  1976-10       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.